Pharmacokinetic-pharmacodynamic modelling: history and perspectives

Journal of Pharmacokinetics and Pharmacodynamics
Chantal Csajka, Davide Verotta


A major goal in clinical pharmacology is the quantitative prediction of drug effects. The field of pharmacokinetic-pharmacodynamic (PK/PD) modelling has made many advances from the basic concept of the dose-response relationship to extended mechanism-based models. The purpose of this article is to review, from a historical perspective, the progression of the modelling of the concentration-response relationship from the first classic models developed in the mid-1960s to some of the more sophisticated current approaches. The emphasis is on general models describing key PD relationships, such as: simple models relating drug dose or concentration in plasma to effect, biophase distribution models and in particular effect compartment models, models for indirect mechanism of action that involve primarily the modulation of endogenous factors, models for cell trafficking and transduction systems. We show the evolution of tolerance and time-variant models, non- and semi-parametric models, and briefly discuss population PK/PD modelling, together with some example of more recent and complex pharmacodynamic models for control system and nonlinear HIV-1 dynamics. We also discuss some future possible directions for PK/PD modelling, report equ...Continue Reading


Jul 30, 2008·Cancer Chemotherapy and Pharmacology·Francesca Del BeneMaurizio Rocchetti
Apr 22, 2010·Cancer Chemotherapy and Pharmacology·Cathrine L Denton, Daniel L Gustafson
Dec 13, 2006·Journal of Pharmacokinetics and Pharmacodynamics·Ronald A Siegel
Sep 18, 2007·Journal of Pharmacokinetics and Pharmacodynamics·Sanyi Tang, Yanni Xiao
Mar 6, 2010·Journal of Pharmacokinetics and Pharmacodynamics·Philippe JacqminJanet R Wade
May 11, 2010·Journal of Pharmacokinetics and Pharmacodynamics·Davide Verotta
Apr 11, 2013·Journal of Pharmacokinetics and Pharmacodynamics·N AsmanovaA I Ilin
Nov 13, 2008·The AAPS Journal·Liping ZhangBernd Meibohm
Oct 23, 2012·Environmental Health Perspectives·Lauren ZeiseKathryn Z Guyton
Mar 1, 2014·Journal of Pharmacokinetics and Pharmacodynamics·Michael G ZagerShaoxian Sun
Feb 25, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Paolo DentiNeil H Davies
Sep 1, 2006·Expert Opinion on Drug Discovery·Christian HöchtCarlos A Taira
Jul 1, 2010·Expert Opinion on Drug Discovery·Cornelia CarstensHolger Becker
Sep 17, 2011·Expert Opinion on Drug Metabolism & Toxicology·David Stepensky
Mar 1, 2009·Expert Opinion on Drug Discovery·Scott Summerfield, Phil Jeffrey
Jun 15, 2010·Expert Opinion on Drug Metabolism & Toxicology·Jong Hwan SungMichael L Shuler
Apr 1, 2010·Expert Opinion on Drug Discovery·Satyendra SuryawanshiBernd Meibohm
Oct 5, 2011·Journal of Pharmaceutical Sciences·Matthew D Thompson, Daniel A Beard
Aug 23, 2012·Journal of Pharmaceutical Sciences·Malcolm RowlandVinod P Shah
Nov 28, 2012·Journal of Theoretical Biology·Sridhar RamakrishnanJaques Reifman
Jul 16, 2010·Computer Methods and Programs in Biomedicine·Ron J KeizerAlwin D R Huitema
Apr 30, 2008·Journal of Pharmacological and Toxicological Methods·Facundo M BerteraChristian Höcht
Jun 15, 2007·Journal of Pharmacological and Toxicological Methods·Facundo M BerteraChristian Höcht
Jul 25, 2009·Pharmaceutical Statistics·Hesham S Al-SallamiStephen B Duffull
Dec 4, 2008·Fundamental & Clinical Pharmacology·Sylvain GoutellePascal Maire
Mar 1, 2012·British Journal of Clinical Pharmacology·Thierry BuclinJeffrey Aronson
Jan 6, 2011·British Journal of Clinical Pharmacology·Stephen B DuffullHelen R Winter
Oct 1, 2010·British Journal of Pharmacology·Georges Vauquelin, Steven J Charlton
Oct 15, 2011·Basic & Clinical Pharmacology & Toxicology·Kuntheavy Ing LorenziniJules Desmeules
Nov 19, 2011·Statistics in Medicine·Michal AbrahamowiczMarie-Pierre Sylvestre
Jan 29, 2011·British Journal of Clinical Pharmacology·Daniel F B WrightStephen B Duffull
Jan 5, 2014·Acta Anaesthesiologica Scandinavica·P VälitaloH Kokki
Aug 30, 2016·Current Pharmacology Reports·Ioannis P Androulakis
Sep 5, 2014·Pharmacoepidemiology and Drug Safety·Rolina D van GaalenDavid L Buckeridge
Apr 23, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Raúl López-ArnauJorge Camarasa
Mar 3, 2009·Drug Metabolism and Pharmacokinetics·Bart A PloegerMeindert Danhof
May 27, 2014·Journal of Theoretical Biology·Sridhar RamakrishnanJaques Reifman
Jun 9, 2016·Toxicology·Frédéric Y BoisAndrew Worth


Feb 1, 1978·Journal of Pharmacokinetics and Biopharmaceutics·B E DahlströmA J Agren
Feb 1, 1979·Journal of Pharmacokinetics and Biopharmaceutics·W G KramerR H Reuning
Nov 1, 1978·British Journal of Anaesthesia·C J HullM J Watson
Mar 1, 1979·Clinical Pharmacology and Therapeutics·L B SheinerJ Ham
Sep 1, 1976·Clinical Pharmacology and Therapeutics·R L GaleazziL B Sheiner
Dec 7, 1992·Journal of Theoretical Biology·M A Nowak, R M May
Jan 1, 1992·Annual Review of Pharmacology and Toxicology·L B Sheiner, T M Ludden
Oct 1, 1991·Journal of Pharmacokinetics and Biopharmaceutics·J A WaldW J Jusko
Sep 1, 1991·Mathematical Biosciences·M A Nowak, R M May
Dec 1, 1991·Journal of Pharmacokinetics and Biopharmaceutics·J W MandemaMeindert Danhof
Dec 1, 1991·Journal of Pharmacokinetics and Biopharmaceutics·Davide Verotta, L B Sheiner
May 1, 1991·Clinical Pharmacology and Therapeutics·T E DunnW J Jusko
May 1, 1991·Journal of Pharmaceutical Sciences·P Veng-PedersenMeindert Danhof
Jan 1, 1990·Fundamental & Clinical Pharmacology·N H Holford
Apr 1, 1989·Journal of Pharmacokinetics and Biopharmaceutics·A I NicholsW J Jusko
Apr 1, 1989·Journal of Pharmacokinetics and Biopharmaceutics·Davide Verotta
Oct 1, 1986·Journal of Pharmacokinetics and Biopharmaceutics·F D BoudinotW J Jusko
Nov 1, 1987·Computer Applications in the Biosciences : CABIOS·Davide Verotta, L B Sheiner
Feb 1, 1988·Anesthesiology·S L ShaferJ C Scott
Jul 1, 1986·Clinical Pharmacology and Therapeutics·J D UnadkatL B Sheiner
Oct 1, 1986·Clinical Pharmacology and Therapeutics·B OosterhuisC J Van Boxtel
Sep 1, 1985·Clinical Pharmacology and Therapeutics·M J ChowM W Fischman
Oct 1, 1972·Computers and Biomedical Research, an International Journal·L B SheinerK L Melmon
Feb 1, 1973·Journal of Pharmaceutical Sciences·T G Theofanous, R G Barile
Dec 1, 1969·Computers and Biomedical Research, an International Journal·L B Sheiner
Jan 1, 1969·Clinical Pharmacology and Therapeutics·R NagashimaG Levy
Apr 1, 1969·Journal of Pharmaceutical Sciences·G LevyW J Jusko
May 1, 1966·Clinical Pharmacology and Therapeutics·G Levy
Dec 22, 1983·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J W Black, P Leff
Jun 1, 1984·Clinical Pharmacology and Therapeutics·E Fuseau, L B Sheiner
Jan 1, 1984·The American Journal of Physiology·R A Meiss
Jun 1, 1982·Clinical Pharmacology and Therapeutics·R ZahlerR Byck
Mar 1, 1981·Computer Programs in Biomedicine·R C BostonM Berman
Jan 1, 1981·Annals of Biomedical Engineering·T J O'Leary, P H Abbrecht
May 1, 1994·Journal of Applied Physiology·I F TroconizDavide Verotta
Oct 1, 1994·Clinical Pharmacology and Therapeutics·G Levy
Nov 1, 1993·Annals of Biomedical Engineering·V Z Marmarelis
Aug 1, 1993·Journal of Pharmacokinetics and Biopharmaceutics·N L DaynekaW J Jusko

Related Concepts

High Performance Computing
Dose-response Relationship
Clinical Pharmacology Discipline
HIV Infections
History,20th Century
Drug Effect

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Sexual Dimorphism in Neurodegeneration

There exist sex differences in neurodevelopmental and neurodegenerative disorders. For instance, multiple sclerosis is more common in women, whereas Parkinson’s disease is more common in men. Here is the latest research on sexual dimorphism in neurodegeneration

HLA Genetic Variation

HLA genetic variation has been found to confer risk for a wide variety of diseases. Identifying these associations and understanding their molecular mechanisms is ongoing and holds promise for the development of therapeutics. Find the latest research on HLA genetic variation here.

Super-resolution Microscopy

Super-resolution microscopy is the term commonly given to fluorescence microscopy techniques with resolutions that are not limited by the diffraction of light. Here are the latest discoveries pertaining to super-resolution microscopy.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Brain Lower Grade Glioma

Low grade gliomas in the brain form from oligodendrocytes and astrocytes and are the slowest-growing glioma in adults. Discover the latest research on these brain tumors here.

CD4/CD8 Signaling

Cluster of differentiation 4 and 8 (CD8 and CD8) are glycoproteins founds on the surface of immune cells. Here is the latest research on their role in cell signaling pathways.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.